Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia (ZENITH)
This study is currently recruiting participants.
Verified May 2013
by Otsuka Pharmaceutical Development & Commercialization, Inc.
Study NCT01397786 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.
First Received on July 11, 2011. Last Updated on May 6, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers